Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Karyopharm Therapeutics (KPTI) Receivables - Other (2016)

Karyopharm Therapeutics' Receivables - Other history spans 1 years, with the latest figure at $154000.0 for Q4 2016.

  • For Q4 2016, Receivables - Other changed N/A year-over-year to $154000.0; the TTM value through Dec 2016 reached $154000.0, changed N/A, while the annual FY2016 figure was $154000.0, N/A changed from the prior year.
  • Receivables - Other reached $154000.0 in Q4 2016 per KPTI's latest filing.
  • In the past five years, Receivables - Other ranged from a high of $154000.0 in Q4 2016 to a low of $154000.0 in Q4 2016.